Division of Nephrology and Hypertension, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
Mayo Clin Proc. 2011 Apr;86(4):282-90. doi: 10.4065/mcp.2010.0821.
To test the hypothesis that kidney function and metabolic risk factors are associated with glomerular density on renal biopsy samples from healthy adults.
This study compared glomerular density with predonation kidney function, blood pressure, and metabolic risk factors in living kidney donors at Mayo Clinic in Rochester, MN, from May 10, 1999, to February 4, 2009. During implantation of the kidney allograft, an 18-gauge core needle biopsy sample of the renal cortex was obtained, sectioned, and examined by pathologists. Glomerular density was determined by the number of glomeruli (normal and sclerotic) divided by area of cortex.
The study sample of 1046 kidney donors had a mean of 21 glomeruli (0.8 sclerotic glomeruli) and a glomerular density of 2.3 glomeruli per square millimeter. In a subset of 54 donors, glomerular density inversely correlated with the mean glomerular area (r(s) = -0.28). Independent predictors of decreased glomerular density were older age, increased glomerular filtration rate, family history of end-stage renal disease, increased serum uric acid, and increased body mass index. Increased urine albumin excretion, hypertension, decreased high-density lipoprotein cholesterol, and metabolic syndrome were also associated with decreased glomerular density after age-sex adjustment. These associations were not explained by the presence of glomerulosclerosis, tubular atrophy, interstitial fibrosis, or arteriosclerosis on the renal biopsy sample. In older donors, decreased glomerular density was attenuated by an increased prevalence of glomerulosclerosis and tubular atrophy.
Decreased glomerular density is associated with many different kidney function and metabolic risk factors among relatively healthy adults and may represent an early state of increased risk of parenchymal injury.
检验假设,即肾功能和代谢危险因素与健康成年人肾活检样本中的肾小球密度有关。
本研究比较了 1999 年 5 月 10 日至 2009 年 2 月 4 日在明尼苏达州罗彻斯特的梅奥诊所的活体供肾者的供肾前肾功能、血压和代谢危险因素与肾小球密度。在移植肾移植过程中,从肾皮质获得一个 18 号针芯活检样本,进行切片并由病理学家检查。肾小球密度通过肾小球(正常和硬化)的数量除以皮质面积来确定。
这项研究的 1046 名供体样本平均有 21 个肾小球(0.8 个硬化肾小球)和 2.3 个肾小球/平方毫米的肾小球密度。在 54 名供体的一个子集中,肾小球密度与平均肾小球面积呈负相关(r(s) = -0.28)。肾小球密度降低的独立预测因素是年龄较大、肾小球滤过率增加、终末期肾病家族史、血尿酸升高和体重指数增加。尿白蛋白排泄增加、高血压、高密度脂蛋白胆固醇降低和代谢综合征在年龄和性别调整后也与肾小球密度降低有关。这些关联不能用肾活检样本中的肾小球硬化、肾小管萎缩、间质纤维化或动脉硬化来解释。在年龄较大的供体中,肾小球密度降低的程度因肾小球硬化和肾小管萎缩的患病率增加而减弱。
在相对健康的成年人中,肾小球密度降低与许多不同的肾功能和代谢危险因素有关,可能代表实质损伤风险增加的早期状态。